File this underneath ‘How curious.’
After generic variations of a key hepatitis B therapy debuted in 2014, they helped sufferers lower your expenses over the following few years. But on the identical time, the common out-of-pocket spending on these generics really rose, regardless that almost a dozen copycat variations had been accessible, suggesting competitors did not work sufficiently.
